A Study to Examine Proteins from Chronic Otitis Media Fluid Samples in Patients undergoing Myringotomy and Possibly a Tube Insertion Procedure

Overview

About this study

During myringotomy and possibly a tube insertion procedure a small amount of fluid that is being removed from the middle ear (whether or not you participate in the study) will be examined for different proteins or it may be saved and used for future research studies.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria:

  • Patients with a diagnosis of eosinophilic otitis media (EOM)
    • undergoing the standard therapy of a low risk myringotomy and tube insertion along with evacuating and discarding the middle ear fluid plus or minus topical steroid therapy
  • Control group 
    • Adults over the age of 18 who undergo myringotomy and tube insertion for chronic serous otitis media

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Brian Neff, M.D.

Closed for enrollment

Contact information:

David Barrs M.D.

(480)301-9692

Barrs.David@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Brian Neff, M.D.

Open for enrollment

Contact information:

Nicole Tombers R.N., CCRP

(507)538-1392

Tombers.Nicole@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20314298

Mayo Clinic Footer